MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathies
MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathies
Recruiting · NCT06555237 · Registry updated 2024-08-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathies | Cardiomegaly, Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Craniofacial Abnormalities, Hypertrophy, Musculoskeletal Abnormalities, Noonan syndrome, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, cardiomyopathy, cardiovascular disorder, congenital heart disease, connective tissue disorder, heart disorder, musculoskeletal system disorder | Recruiting | Phase 2 | 2024-08-15 | NCT06555237 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Medical University of Warsaw | 89 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Paediatrics, The Medical University of Warsaw, Poland | Warsaw | Poland | 1 |